These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31548012)
1. Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine. Kumru OS; Saleh-Birdjandi S; Antunez LR; Sayeed E; Robinson D; van den Worm S; Diemer GS; Perez W; Caposio P; Früh K; Joshi SB; Volkin DB Vaccine; 2019 Oct; 37(44):6696-6706. PubMed ID: 31548012 [TBL] [Abstract][Full Text] [Related]
2. Development of Robust Freeze-Drying Process for Long-Term Stability of rVSV-SARS-CoV-2 Vaccine. Khan MDFH; Youssef M; Nesdoly S; Kamen AA Viruses; 2024 Jun; 16(6):. PubMed ID: 38932234 [TBL] [Abstract][Full Text] [Related]
3. Development of stable liquid formulations for adenovirus-based vaccines. Evans RK; Nawrocki DK; Isopi LA; Williams DM; Casimiro DR; Chin S; Chen M; Zhu DM; Shiver JW; Volkin DB J Pharm Sci; 2004 Oct; 93(10):2458-75. PubMed ID: 15349956 [TBL] [Abstract][Full Text] [Related]
4. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations. Jiang G; Goss M; Li G; Jing W; Shen H; Fujimori K; Le L; Wong L; Wen ZQ; Nashed-Samuel Y; Riker K; Germansderfer A; Tsang P; Ricci M PDA J Pharm Sci Technol; 2013; 67(4):323-35. PubMed ID: 23872443 [TBL] [Abstract][Full Text] [Related]
5. Physical Characterization and Stabilization of a Lentiviral Vector Against Adsorption and Freeze-Thaw. Kumru OS; Wang Y; Gombotz CWR; Kelley-Clarke B; Cieplak W; Kim T; Joshi SB; Volkin DB J Pharm Sci; 2018 Nov; 107(11):2764-2774. PubMed ID: 30017889 [TBL] [Abstract][Full Text] [Related]
6. Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate. Patel A; Erb SM; Strange L; Shukla RS; Kumru OS; Smith L; Nelson P; Joshi SB; Livengood JA; Volkin DB Vaccine; 2018 May; 36(22):3169-3179. PubMed ID: 28506515 [TBL] [Abstract][Full Text] [Related]
7. Tiny steps towards an HIV vaccine. Willyard C Nature; 2010 Jul; 466(7304):S8. PubMed ID: 20631706 [No Abstract] [Full Text] [Related]
15. Strategies for improved stability of Peste des Petits Ruminants Vaccine. Silva AC; Carrondo MJ; Alves PM Vaccine; 2011 Jul; 29(31):4983-91. PubMed ID: 21570436 [TBL] [Abstract][Full Text] [Related]
16. Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates. Takahashi MN; Rolling JA; Owen KE Virol J; 2010 Feb; 7():39. PubMed ID: 20163742 [TBL] [Abstract][Full Text] [Related]
17. Development of replication-competent viral vectors for HIV vaccine delivery. Parks CL; Picker LJ; King CR Curr Opin HIV AIDS; 2013 Sep; 8(5):402-11. PubMed ID: 23925000 [TBL] [Abstract][Full Text] [Related]
19. Ectoine and Hydroxyectoine Stabilize Antibodies in Spray-Dried Formulations at Elevated Temperature and during a Freeze/Thaw Process. Nayak PK; Goode M; Chang DP; Rajagopal K Mol Pharm; 2020 Sep; 17(9):3291-3297. PubMed ID: 32672979 [TBL] [Abstract][Full Text] [Related]